This website is intended for US healthcare professionals only.

  • Contact Us
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
  • Disease State Information & Resources
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
BioCryst logo
  • BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
  • The suprachoroidal pathway: a new drug delivery route to the back of the eye

    View Article

    biocryst

    January 27, 2025
    Diabetic Macular Edema (DME)
  • Microinjection via the suprachoroidal space: a review of a novel mode of administration

    View Article

    biocryst

    January 27, 2025
    Diabetic Macular Edema (DME)
  • Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema 

    View Article

    biocryst

    January 27, 2025
    Diabetic Macular Edema (DME)
  • Characterization of the Vitreous Proteome in Diabetes without Diabetic Retinopathy and Diabetes with Proliferative Diabetic Retinopathy

    View Article

    biocryst

    January 27, 2025
    Diabetic Macular Edema (DME)
  • Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

    View Article

    biocryst

    January 27, 2025
    Diabetic Macular Edema (DME)
  • The Role of Plasma Kallikrein–Kinin Pathway in the Development of Diabetic Retinopathy: Pathophysiology and Therapeutic Approaches

    View Article

    biocryst

    January 27, 2025
    Diabetic Macular Edema (DME)
  • Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies

    View Article

    biocryst

    January 27, 2025
    Diabetic Macular Edema (DME)
  • Plasma Kallikrein Mediates Vascular Endothelial Growth Factor-Induced Retinal Dysfunction and Thickening

    View Article

    biocryst

    January 27, 2025
    Diabetic Macular Edema (DME)
  • Molecules related to diabetic retinopathy in the vitreous and involved pathways

    View Article

    biocryst

    January 27, 2025
    Diabetic Macular Edema (DME)
  • Plasma kallikrein-kinin system and diabetic retinopathy

    View Article

    biocryst

    January 27, 2025
    Diabetic Macular Edema (DME)
Previous Page
1 … 6 7 8 9
Next Page
BioCryst logo

2025 BioCryst Pharmaceuticals, Inc.
All Rights Reserved

  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Site Map
Close

You are now leaving biocrystmedical.com.

BioCryst is not responsible for and has no control over the content of linked sites.

Stay on Site Continue

This website is intended for healthcare professionals practicing in the US.

Are you a US healthcare professional? If not, you will be redirected to biocryst.com.

No, I am not a US healthcare professional Yes, I am a US healthcare professional